Results 131 to 140 of about 12,902 (159)

Unraveling antibody-induced structural dynamics in the ADAMTS13 CUB1-2 domains via HDX-MS. [PDF]

Blood Adv
Bonnez Q, Legan ER, Pareyn I, Boudry F, Anckaert J, Tersteeg C, De Meyer SF, Li R, Vanhoorelbeke K.   +8 more
europepmc   +1 more source

Prospective Study of ADAMTS13 and von Willebrand Factor's Role in the Prediction of Outcomes in Acute Ischemic Stroke. [PDF]

J Clin Med
Makris M, Gavriilaki E, Ztriva E, Evangelidis P, Lefkou E, Vlachaki E, Bountola S, Perifanis V, Matsagkas M, Savopoulos C, Kaiafa G.   +10 more
europepmc   +1 more source

Thrombotic Thrombocytopenic Purpura and Evans Syndrome: Validating and Exploring 20 Years of Routine Hospital Care. [PDF]

J Blood Med
Lawrie DA, Hansen DL, Kristensen TL, Carlsen SBIS, Hannig LH, Pedersen PT, Kristensen HB, Lorenzen MOB, Stentoft J, Van Kooten Niekerk PB, Jørgensen MP, Severinsen MT, Dorff MH, Pedersen RS, Glenthøj A, Frederiksen H.   +15 more
europepmc   +1 more source

N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP. [PDF]

Blood Adv
Postmus T, Schilder N, Ferreira de Santana J, Langerhorst P, Kaijen P, Coppo P, Joly BS, Veyradier A, Vanhoorelbeke K, Voorberg J.   +9 more
europepmc   +1 more source

A predictive algorithm involving lactate dehydrogenase to serum creatinine ratio may assist in identifying patients with thrombotic thrombocytopenic purpura. [PDF]

Ann Hematol
Chen X, Zhang J, Fu J, Lin X, Li W, Wu Z, Cai R, Wei L, Luo X.   +8 more
europepmc   +1 more source

Challenges in managing iTTP: insights into ADAMTS13 inhibitor boosting during caplacizumab therapy. [PDF]

Ann Hematol
Tanaka H, Sakai K, Tamura S, Shiwaku H, Nakamura J, Ueda Y, Bamba S, Nishikubo M, Nagai Y, Matsumoto M.   +9 more
europepmc   +1 more source

A peculiar case report of primary iTTP in a previously healthy Saudi man. [PDF]

J Med Life
Balasubramanian A, AlMurad B, AlFarrah N, AbuSamrah B, AbulKhoudoud N.   +4 more
europepmc   +1 more source

VWF-ADAMTS13 imbalance bridges infection to stroke. [PDF]

Blood Adv
Dong JF, Han C.
europepmc   +1 more source

The third form of thrombotic thrombocytopenic purpura shows up again: what is it, does it even exist, how to find out? Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura". [PDF]

Haematologica
Lämmle B.
europepmc   +1 more source

Beyond the Limits of Conventional Coagulation Tests: A Comprehensive Overview of ACLF-Related Coagulopathies. [PDF]

J Clin Med
Kurpiewska D, Kośnik A, Bieliński K, Raszeja-Wyszomirska J.   +3 more
europepmc   +1 more source